Works matching DE "PROGRESSION-free survival"
Results: 5000
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 2, p. 53, doi. 10.1007/s40267-024-01050-3
- By:
- Publication type:
- Article
The use of intraperitoneal chemotherapy for advanced ovarian cancer – The experience of a tertiary referral centre.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2024, v. 64, n. 3, p. 239, doi. 10.1111/ajo.13767
- By:
- Publication type:
- Article
The Impact of Intrauterine Manipulators on Outcome and Recurrence Patterns of Endometrial Cancer Patients Undergoing Minimally Invasive Surgery.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 3, p. 355, doi. 10.1089/jwh.2023.0246
- By:
- Publication type:
- Article
Update on Breast Cancer.
- Published in:
- Journal of Women's Health (15409996), 2023, v. 32, n. 7, p. 736, doi. 10.1089/jwh.2023.0213
- By:
- Publication type:
- Article
Novel Mahalanobis-based feature selection improves one-class classification of early hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 481, doi. 10.1007/s10555-023-10163-6
- By:
- Publication type:
- Article
MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 4, p. 771, doi. 10.1007/s10555-019-09826-0
- By:
- Publication type:
- Article
WNT5A as a therapeutic target in breast cancer.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 4, p. 767, doi. 10.1007/s10555-018-9760-y
- By:
- Publication type:
- Article
Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05544-1
- By:
- Publication type:
- Article
Clinical effectiveness and safety of tislelizumab plus TKI as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): a single-center retrospective study.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05443-5
- By:
- Publication type:
- Article
Regression and growth rates in androgen deprivation therapy for advanced castration-sensitive prostate cancer.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05316-3
- By:
- Publication type:
- Article
Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05321-6
- By:
- Publication type:
- Article
Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05290-w
- By:
- Publication type:
- Article
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05252-2
- By:
- Publication type:
- Article
Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.
- Published in:
- Transplant International, 2016, v. 29, n. 4, p. 403, doi. 10.1111/tri.12736
- By:
- Publication type:
- Article
Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients.
- Published in:
- Transplant International, 2015, v. 28, n. 11, p. 1332, doi. 10.1111/tri.12638
- By:
- Publication type:
- Article
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer with peritumoral abscesses and fistulas.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 2, p. 201, doi. 10.1007/s00066-021-01878-y
- By:
- Publication type:
- Article
Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 1, p. 39, doi. 10.1007/s00066-021-01868-0
- By:
- Publication type:
- Article
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 1, p. 56, doi. 10.1007/s00066-021-01834-w
- By:
- Publication type:
- Article
Survival analysis of elderly patients with osteosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fungation in soft tissue sarcomas is associated with poor survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Use of dual-mobility cup in revision hip arthroplasty reduces the risk for further dislocation: analysis of seven hundred and ninety one first-time revisions performed due to dislocation, reported to the Swedish Hip Arthroplasty Register.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bousquet dual mobility socket for patient under fifty years old. More than twenty year follow-up of one hundred and thirty one hips.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 8, p. 2421, doi. 10.1007/s00417-024-06434-9
- By:
- Publication type:
- Article
Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 10, p. 3127, doi. 10.1007/s00417-021-05236-7
- By:
- Publication type:
- Article
Modified types of orbital exenteration, survival, and reconstruction.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 10, p. 2305, doi. 10.1007/s00417-020-04812-7
- By:
- Publication type:
- Article
Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 3, p. 383, doi. 10.1007/s00228-024-03797-0
- By:
- Publication type:
- Article
Is nivolumab alone or in combination with ipilimumab more effective for treating lung cancer? a meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 2, p. 269, doi. 10.1007/s00228-024-03789-0
- By:
- Publication type:
- Article
Racial/ethnic differences in survival and treatment response with PD-1/PD-L1 inhibitors in resectable non-small cell lung cancer: a meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 139, doi. 10.1007/s00228-024-03777-4
- By:
- Publication type:
- Article
Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1697, doi. 10.1007/s00228-024-03734-1
- By:
- Publication type:
- Article
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 10, p. 1425, doi. 10.1007/s00228-024-03718-1
- By:
- Publication type:
- Article
Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1387, doi. 10.1007/s00228-024-03715-4
- By:
- Publication type:
- Article
The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1259, doi. 10.1007/s00228-024-03695-5
- By:
- Publication type:
- Article
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 941, doi. 10.1007/s00228-024-03668-8
- By:
- Publication type:
- Article
The safety and efficacy of dabrafenib and trametinib in patients with glioma: A systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 5, p. 639, doi. 10.1007/s00228-024-03635-3
- By:
- Publication type:
- Article
The sound and surprise: overlapping meta-analyses on the topic of safety and efficacy of PD-1 and PD-L1 inhibitors in the treatment of non-small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 12, p. 1665, doi. 10.1007/s00228-023-03577-2
- By:
- Publication type:
- Article
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 485, doi. 10.1007/s00228-023-03464-w
- By:
- Publication type:
- Article
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 503, doi. 10.1007/s00228-023-03452-0
- By:
- Publication type:
- Article
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 243, doi. 10.1007/s00228-022-03435-7
- By:
- Publication type:
- Article
Radiotherapy for pediatric low-grade glioma.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 10, p. 3277, doi. 10.1007/s00381-024-06460-2
- By:
- Publication type:
- Article
Doing more with less: surgical results of pediatric posterior fossa tumors from a single center in Latin America.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 9, p. 2713, doi. 10.1007/s00381-024-06539-w
- By:
- Publication type:
- Article
Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 6, p. 1671, doi. 10.1007/s00381-024-06329-4
- By:
- Publication type:
- Article
Surgical management of Rathke cleft cysts in pediatric patients: a single institution experience.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 5, p. 1367, doi. 10.1007/s00381-024-06277-z
- By:
- Publication type:
- Article
Anatomy of the posterior Fossa: a comprehensive description for pediatric brain tumors.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 3, p. 613, doi. 10.1007/s00381-023-06220-8
- By:
- Publication type:
- Article
Lateral-type posterior fossa ependymomas in pediatric patients: a national collaborative study.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 2, p. 407, doi. 10.1007/s00381-023-06194-7
- By:
- Publication type:
- Article
Pediatric atypical extraventricular neurocytoma: Clinical features and survival outcomes.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 12, p. 3475, doi. 10.1007/s00381-023-06023-x
- By:
- Publication type:
- Article
Pediatric pineal region masses: a single-center experience over 25 years.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 9, p. 2307, doi. 10.1007/s00381-022-05593-6
- By:
- Publication type:
- Article
Evaluating the efficacy and safety of single-agent etoposide intra-CSF chemotherapy in children and young people with relapsed/refractory central nervous system tumours.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 6, p. 1537, doi. 10.1007/s00381-023-05872-w
- By:
- Publication type:
- Article
Comparison of the clinical features and treatment outcomes of pilocytic astrocytoma in pediatric and adult patients.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 3, p. 583, doi. 10.1007/s00381-023-05839-x
- By:
- Publication type:
- Article
Central neurocytomas in children: Clinicopathologic features and long-term surgical outcomes.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 1, p. 141, doi. 10.1007/s00381-022-05663-9
- By:
- Publication type:
- Article